|
Back to EZorb Newsletter Index |
|
In this issue:
1. Share Success: Letters From Readers Letter I: From Barbara P. Hi, my name is Barbara. I was diagnosed with bone spurs in my neck a couple of years ago. I have been taking EZorb Calcium for almost three years. For the past two months, I have not taken any of Ezorb. I notice an increase of pain and more pain in my mid back where I have had arthritis issues. I just made another order of 3 bottles of the Ezorb Calcium! Letter II:
From Gloria R. Thank for your quick reply. I must admit, since myself have started both products, approx. 2.1/2 weeks ago I feel more energetic and a sense of well being. Have small bones, lost lots of weight 2 months ago because I was scared of going into dialysis. Improved bone density will come with time, and hopefully some weight, as I look aneurexic right now. BTW my sister’s Neurologist says he doesn’t know MARVLIX, so I am giving it to her anyway, don’t think it would affect the Prednisone and Mycopholinate she is on. Seeing how good I feel I think it would help her anyway. Tks again From the Desk of EZorb Newsletter Editor:Our newsletter reaches over 200,000 subscribers worldwide. Success stories you shared in the past have made a great impact on many people's life. Please email your story to sharesuccess @ ezorbonline.com or simply post it to Testimonial Submit Form. Your personal information will never be revealed to the public. 2. Research News: Cost Drives One in Six Diabetics to Ration InsulinFindings from a nationally representative US survey show that a substantial minority of people with diabetes ration their use of insulin because of issues with affordability. As reported in the Annals of Internal Medicine, Adam Gaffney (Cambridge Health Alliance, Massachusetts, USA) and colleagues looked at the responses of 982 people with insulin-treated diabetes who participated in the 2021 National Health Interview Survey. In total, 16.5% of these people reported having rationed insulin use for financial reasons over the preceding 12 months. The researchers say this equates to 1.3 million adults with diabetes nationwide having rationed insulin during the study period. The most common form of rationing to save money among people with type 1 diabetes was taking less insulin, at 16.5%, and 14.4% had at some point delayed buying insulin to save money. People with type 2 diabetes were more likely to delay buying insulin, at 13.8%, than to reduce the amount used, at 9.5%. Skipping an insulin dose to save money was the least frequent form of rationing; nevertheless, 8.1% of people with type 1 diabetes and 10.4% of those with type 2 diabetes reported having done this. The highest rate of insulin rationing was seen among uninsured people, at 29.2%, but the researchers note that “it was also common among adults with private coverage [at 18.8%], which often requires higher cost sharing than public insurance.” Other groups with high rates of rationing were people younger than 65 years, at 20.4% versus 11.2% of older people, and Black people, at 23.2% versus 16.0% of those with White or Hispanic ethnicity. Finally, Gaffney and team found that rationing insulin was significantly and independently associated with a 1.48-fold increased likelihood of feeling overwhelmed by the demands of living with diabetes. “By limiting insulin copays to $35 per month under Medicare, the 2022 Inflation Reduction Act may improve insulin access for seniors, who experienced substantial rationing in our study,” they conclude. “However, a similar cap for the privately insured was removed from the bill, and copay caps do not aid the uninsured. Further reform could improve access to insulin for all Americans.” Original research was published in Ann Intern Med 2022; doi:10.7326/M22-2477. 3. Useful LinksEZorb - Frequently Asked Questions & Answers 4. What Are Others Saying About EZorb and Marvlix?EZorb and Marvlix have restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb and Marvlix. |
|
Back to EZorb Newsletter Index |